Adult Gliosarcoma — Trials

Adult Gliosarcoma — Trials · CancerIndex

Clinical trials

Registered studies

81 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 4
Recruiting: 2
Ph III recruiting: 0
Growth YoY: —
Industry share: 25%
Top sponsor: James Markert, MD
Termination share: 45.5%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (21)

clinicaltrialsPublishedShowing 51–56 of 56 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00014170	Gefitinib in Treating Patients With Newly Diagnosed Glioblastoma Multiforme	completed	Phase 2	92	National Cancer Institute (NCI)NIH	1	Jul 16, 2013	clinicaltrials
NCT00004262	Radiation Therapy and Gadolinium Texaphyrin in Treating Patients With Supratentorial Glioblastoma Multiforme	completed	Phase 1	12	National Cancer Institute (NCI)NIH	1	Jun 4, 2013	clinicaltrials